WuXi PharmaTech Inc.  (WX) Trade Now »     Rate WX  -  Discuss WX  -  Add to Watch List        

Filed under: International markets, China, Newsletters, Stocks to Buy

This post is part of a 12-article feature on the best bets for investing in China. To see all the other recommendations in this special report, click here.

"Shanghai-based Wuxi PharmaTech (NYSE: WX), a new addition to our model portfolio, is a bargain," says China region expert Jim Trippon.

In his The China Stock Digest, he explains, "In a nutshell, WuXi performs pharmaceutical R&D on a contract basis for paying clients; it provides services to nine of the top ten pharmaceutical companies in the world."

Filed under: International markets, China, Newsletters, Stocks to Buy

"WuXi PharmaTech (Cayman) Inc. (NYSE: WX) provides laboratory and manufacturing services for the drug and medical device R&D process," notes China stock specialist Jim Trippon.

In his The China Stock Digest, he explains, "Because Chinese researchers receive much smaller paychecks than their Western counterparts, Shanghai-based WuXi is able to lower the cost of this research." Here's his review.

"We have often heard major Western pharmaceutical companies complain of the extraordinary cost of discovering and developing drugs.

"WuXi PharmaTech (NYSE: WX) provides laboratory and manufacturing services for the drug and medical device R&D process," notes Jim Trippon.

In his The China Stock Digest, he explains, "Because Chinese researchers receive much smaller paychecks than their Western counterparts, Shanghai-based WuXi is able to lowering the cost of this research." Here's his review.

"We have often heard major Western pharmaceutical companies complain of the extraordinary cost of discovering and developing drugs.

WuXi PharmaTech (WX), a Chinese contract research organization [CRO] put out another good quarter, but this stock never seems to trade in a logical manner;<!----> perhaps the gross margins or lack of "increased" guidance is caused the stock to fall 3% yesterday. It just might be too small or unknown to be attracting enough attention or to trade "normally".